Fresenius Kabi Oncology
(FRESENIUS KABI ONCOLOGY LIMITED)
Founded in 2003
About Fresenius Kabi Oncology
Fresenius Kabi Oncology is a developer and manufacturer of oncology generics. The startup product portfolio includes injectables, oral cytotoxics, cytostatics, intermediates, and Active Pharmaceutical Ingredients (APIs).
Incubators & Accelerators of Fresenius Kabi Oncology
Public Links of Fresenius Kabi Oncology
Frequently Asked Questions (FAQ)
When was Fresenius Kabi Oncology founded?
Fresenius Kabi Oncology was founded in the year 2003.
What is the legal name of Fresenius Kabi Oncology?
The legal name of Fresenius Kabi Oncology is Fresenius Kabi Oncology Limited.
Who are the founders of Fresenius Kabi Oncology?
Fresenius Kabi Oncology is founded by Arvind Kumar Sharma and Pritam Das Narang.
Which Incubators & Accelerators supported Fresenius Kabi Oncology?
What are the focus areas of Fresenius Kabi Oncology?
Who are Fresenius Kabi Oncology's competitors?
Possible competitors of Fresenius Kabi Oncology may include Ace Lifecare Llp, Annweshan Scitech, Ameliorate Biotech and 7 others.
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
